James S Wysock
Overview
Explore the profile of James S Wysock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
871
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lepor H, Cao T, Tafa M, Wysock J
Urol Oncol
. 2025 Feb;
PMID: 39966077
Background: There is increasing interest in ablative focal therapy (AFT) for treating clinically localized prostate cancer. The objective of the present study is to report treatment related complications and regret,...
2.
Kola O, Smigelski M, Nagpal S, Gogaj R, Taneja S, Wysock J, et al.
J Robot Surg
. 2024 Oct;
18(1):387.
PMID: 39470887
Urine leak (UL) and vascular complications (VC), i.e., pseudoaneurysms and arteriovenous fistulas are well-described complications of robotic-assisted partial nephrectomy (RAPN). Historically, UL incidence ranges from 0.3 to 17% and VC...
3.
Lepor H, Rapoport E, Tafa M, Gogaj R, Wysock J
Urology
. 2024 Oct;
196:189-195.
PMID: 39447880
Objective: To assess 5-year oncologic outcomes following primary partial gland cryo-ablation (PPGCA) in intermediate-risk prostate cancer. Methods: Of 476 men undergoing PPGCA enrolled in our prospective oncologic and functional outcomes...
4.
George A, Miocinovic R, Patel A, Lomas D, Correa A, Chen D, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927884
The PRESERVE study (NCT04972097) aims to evaluate the safety and effectiveness of the NanoKnife System to ablate prostate tissue in patients with intermediate-risk prostate cancer (PCa). The NanoKnife uses irreversible...
5.
Pak J, Huang R, Huang W, Lepor H, Wysock J, Taneja S
BJU Int
. 2024 Mar;
134(1):128-135.
PMID: 38533536
Objectives: To evaluate the interaction of patient age and Prostate Imaging-Reporting and Data System (PI-RADS) score in determining the grade of prostate cancer (PCa) identified on magnetic resonance imaging (MRI)-targeted...
6.
Xu A, Thakker S, Sawhney V, Gogaj R, Vokshi F, Wysock J
Can J Urol
. 2024 Feb;
31(1):11767-11774.
PMID: 38401255
Introduction: We evaluate the rate of developing ciprofloxacin resistance in patients undergoing repeat prostate biopsies (PBx), associated risk factors, and impact on complications. Materials And Methods: We retrospectively evaluated pre-procedural...
7.
Lepor H, Rapoport E, Gogaj R, Hernandez H, Wysock J
Urol Oncol
. 2023 Dec;
42(1):20.e1-20.e7.
PMID: 38065805
Background: Prostate cancer treatment-related regret (TRR) incorporates the myriad effects of diagnosis and treatment with associated behavioral, emotional, and interpersonal changes within the context of patient values and expectations. We...
8.
Wysock J, Rapoport E, Hernandez H, Gogaj R, Lepor H
J Urol
. 2023 Aug;
210(3):463-464.
PMID: 37555599
No abstract available.
9.
Wysock J, Rapoport E, Hernandez H, Gogaj R, Lepor H
J Urol
. 2023 Jun;
210(3):454-464.
PMID: 37285232
Purpose: We evaluated 3-year oncologic outcomes following primary partial gland cryoablation. Materials And Methods: Men with unilateral intermediate-risk prostate cancer undergoing primary partial gland cryoablation since March 2017 enrolled in...
10.
Wake N, Rosenkrantz A, Huang R, Ginocchio L, Wysock J, Taneja S, et al.
Abdom Radiol (NY)
. 2023 Feb;
48(4):1401-1408.
PMID: 36749368
Background: Three-dimensional (3D) printed anatomic models can facilitate presurgical planning by providing surgeons with detailed knowledge of the exact location of pertinent anatomical structures. Although 3D printed anatomic models have...